UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
Related Articles

Class of 2022 Shining Stars
On June 11-12, more than 7,000 graduates will be honored in a series of commencement ceremonies for each undergraduate college, the Graduate Division, Rady School of Management and School of Global Policy and St… […]

Faculty Mentor Training Program Strengthens University’s Institutional Climate
A pioneering mentorship program at UC San Diego Health Sciences improved faculty satisfaction, especially among underrepresented faculty. The program serves as a successful model for other universities and medical schools looking to improve faculty diversity and success. Click here to view original post… […]

NSF Director Touts Magnitude of UC San Diego Research and Outreach During Visit
UC San Diego research initiatives, including nanoengineering, earthquake safety and ocean science, received a huge endorsement from the National Science Foundation director and key members of his team during a j… […]